Results 81 to 90 of about 529 (153)

The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and White subjects. [PDF]

Clin Transl Sci, 2022
Hwang S, Lee S, Kim E, Hwang I, Cho JY, Chung JY, Jang IJ, Oh J.   +7 more
europepmc   +1 more source

Safety of Eslicarbazepine Acetate in Elderly Versus Non-Elderly Patients with Focal Seizures: From Pooled Data of Clinical Studies to 8 Years of Post-Marketing Experience. [PDF]

Drug Saf, 2021
Magalhães LM, Costa R, Vieira M, Moreira J, Gama H, Soares-da-Silva P.   +5 more
europepmc   +1 more source

Treatment-induced diabetes neuropathy: description of singular clinical signs to reach a prompt diagnosis. [PDF]

BMJ Case Rep, 2020
Guisado Vasco P, Llanero-Luque M, Cano-Megías M, Cortés-Berdonces M.   +3 more
europepmc   +1 more source

Three-step process for the synthesis of 10,11-dihydro-5<i>H</i>-dibenzo[<i>b</i>,<i>f</i>]azepin-10-ol derivatives. [PDF]

RSC Adv
Sroor FM, Terme T, Vanelle P, Spitz C.
europepmc   +1 more source

Therapeutic and prognostic implications of NOTCH and MAPK signaling in bladder cancer. [PDF]

Cancer Sci, 2021
Schulz GB, Elezkurtaj S, Börding T, Schmidt EM, Elmasry M, Stief CG, Kirchner T, Karl A, Horst D.   +8 more
europepmc   +1 more source

Economic evaluation of brivaracetam in the adjunctive treatment of patients with focal-onset seizure in Jordan. [PDF]

Medicine (Baltimore)
Halloush S, Alkhatib NS, Alfayez OM, Alkhezi OS, Al Froukh R, Radaideh F, Naser AY.   +6 more
europepmc   +1 more source

Psychiatric adverse events in three phase III trials of eslicarbazepine acetate for focal seizures. [PDF]

Epilepsia Open, 2022
Altalib H, Grinnell T, Cantu D, Ikedo F, Vieira M, Zhang Y, Blum D.   +6 more
europepmc   +1 more source

Safety and Efficacy of Eslicarbazepine Acetate in Children Diagnosed With a Focal Seizure Disorder: A Systematic Review and Meta-Analysis. [PDF]

Brain Behav
Das NB, Haq MZU, Anwar E, Das M, Asif A, Naeem U, Khan MM, Arshad M, Javed S, Akilimali A.   +9 more
europepmc   +1 more source

Cell differentiation is disrupted by MYO5B loss through Wnt/Notch imbalance. [PDF]

JCI Insight, 2021
Kaji I, Roland JT, Rathan-Kumar S, Engevik AC, Burman A, Goldstein AE, Watanabe M, Goldenring JR.   +7 more
europepmc   +1 more source

Development and Utility of a PAK1-Selective Degrader. [PDF]

J Med Chem, 2022
Chow HY, Karchugina S, Groendyke BJ, Toenjes S, Hatcher J, Donovan KA, Fischer ES, Abalakov G, Faezov B, Dunbrack R, Gray NS, Chernoff J.   +11 more
europepmc   +1 more source